Patient factors including socioeconomic status account for much variation in kidney transplant access
FRIDAY, May 29, 2020 (HealthDay News) — Patient factors account for much of the variation in access to kidney transplantation in the United Kingdom, according to a study published online May 28 in the Clinical Journal of the American Society of Nephrology.
Rishi Pruthi, Ph.D., from Guy’s and St. Thomas’ National Health Service Foundation Trust in London, and colleagues conducted a prospective observational cohort study at 72 U.K. kidney centers to assess equity in access to kidney transplantation in the presence of a universal health care system. Incident renal replacement therapy (RRT) patients were analyzed to assess preemptive listing and listing within two years of starting dialysis.
The researchers found that 26 percent of 2,676 incident RRT patients were preemptively listed, while 30 percent of 1,970 patients starting dialysis were listed within two years of dialysis initiation. Increasing age, most comorbidities, body mass index >35 kg/m², and lower socioeconomic status were patient factors associated with reduced likelihood of being listed and accounted for much of the intercenter variation. There were inconsistent associations seen for ethnic minority, while reduced access was only observed for preemptive listing. Transplanting center status and a universal approach to discussing transplantation was associated with higher preemptive listing (odds ratios, 3.1 and 1.4, respectively).
“Findings from the United Kingdom make it apparent that barriers to transplantation are not limited to the availability of health care coverage,” write the authors of an accompanying editorial.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Prep for Conservative Management, Dialysis Yield Similar Results in Older Patients With Kidney Failure
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
AI Better Assesses Heart Function From MRI Than Clinicians
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer